Navigation Links
Enrollment in Employer-Contracted Pharmacy Benefit 'Carve-Out' Increased by More than Six Million Lives
Date:4/6/2009

As Employers Continue Shift to Self-Insurance for Medical Benefits, Movement to Direct Contracting for Pharmacy Benefits Also Underway, According to Data from HealthLeaders-InterStudy

NASHVILLE, Tenn., April 6 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that between January 2008 and July 2008 enrollment in pharmacy benefit plans for which employers contract directly with a pharmacy benefit manager (PBM), also known as a "carve-out," increased by more than six million lives to 55.9 million, a nearly 13 percent increase. Data to support this trend, and other enrollment information, can be found in the latest release of Managed Market Surveyor-Rx, a database product from HealthLeaders-InterStudy that delivers medical and pharmacy benefit enrollment by managed care organization and geography.

During the same period, HealthLeaders-InterStudy data reveals that self-insured medical enrollment grew by 1.6 million lives, or 2.2 percent, to more than 75.3 million members nationwide. By assuming more risk, employers can reduce the overall premium costs for each employee through the elimination of premium taxes, risk charges and other costs.

"Contracting directly with pharmacy benefit managers offers employers more options for benefit design and co-pay structure, enabling them to improve control of their drug benefit spending," said Lance Wolkenbrod, data analyst with HealthLeaders-InterStudy. "As companies continue to look for ways to better control costs, we'll likely see this trend continue as more employers move to direct contracting with pharmacy benefit managers."

Why Pharmaceutical Companies Need Managed Market Surveyor-Rx

Managed Market Surveyor-Rx delivers medical and pharmacy benefit enrollment data by managed care organization and geography (national, state, MSA) to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy's proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

    For more information, contact:

    Lisa Osgood                                 Elizabeth Marshall
    HealthLeaders-InterStudy                    Decision Resources, Inc.
    781-296-2606                                781-296-2563
    losgood@hl-isy.com                          emarshall@dresources.com


       All company, brand, or product names contained in this document may be
         trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Governor Rendell Announces CHIP Enrollment Clinics at Several Rite Aid Stores
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
4. New Online Tool Makes Enrollment in Blue Cross of California Easier
5. Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies
6. My Medicare Matters(TM) Advises Evaluating Your Current Medicare Part D Plan During Open Enrollment
7. Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study
8. Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinsons Disease
9. 2008 Open Enrollment for Medicare Part D Prescription Drug Coverage and Medicare Advantage Plans Begins Today
10. Medicare Rx Beneficiaries Urged to Review Changes to Their Drug Plans and Compare with Other Plans During Open Enrollment
11. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is ... the treatment of acute or chronic problems, I focus on preventative care with all my ... If you have any questions, always feel free to contact my office and my trained ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement ... quarterback position. The former overall number one pick in the 2001 NFL Draft, to ... holds the record for the most career rushing yards by a quarterback (6,109) and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... SAN DIEGO , April 18, 2017  Astute ... previewed a case series to be presented at the ... , which begins today and continues through April 22. ... and IGFBP-7 , used to assess risk for acute ... acute decompensated heart failure (ADHF). Elevated ...
Breaking Medicine Technology: